Back
KOSE Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
53
KSRYY
KOSE
Last Price:
13.93
Seasonality Move:
-9.25%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
37.44
Seasonality Move:
3.65%
Buy
53
KOSE (KSRYY)
is a Buy
Is KOSE a Buy, Sell or Hold?
- The current KOSE [KSRYY] share price is $13.93. The Score for KSRYY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- KSRYY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $37.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
KSRYY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 67.68 | Buy |
| Chaikin Money Flow: | 636 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.39 - 13.63) | Buy |
| Bollinger Bands (100): | (10.16 - 12.78) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.58 | Sell |
| Relative Strength Index (14 RSI): | 37.74 | Sell |
| Chaikin Money Flow: | -836354 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.26 - 42.36) | Sell |
| Bollinger Bands (100): | (41.26 - 48.86) | Sell |
KSRYY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.64 | Buy |
| 20-day SMA: | 13.13 | Buy |
| 50-day SMA: | 11.76 | Buy |
| 200-day SMA: | 12.95 | Buy |
| 8-day EMA: | 13.69 | Buy |
| 20-day EMA: | 13.18 | Buy |
| 50-day EMA: | 12.33 | Buy |
| 200-day EMA: | 13.43 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.11 | Sell |
| 20-day SMA: | 40.61 | Sell |
| 50-day SMA: | 42.43 | Sell |
| 200-day SMA: | 42.45 | Sell |
| 8-day EMA: | 40.32 | Sell |
| 20-day EMA: | 40.92 | Sell |
| 50-day EMA: | 42.29 | Sell |
| 200-day EMA: | 43.55 | Sell |
KOSE Earnings Growth & KSRYY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
KOSE Technical Analysis
| Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||